The North America Pharmaceutical Suspension Market would witness market growth of 3.3% CAGR during the forecast period (2023-2030).
Pharmaceutical suspensions are extensively used in pediatric medicine, addressing the challenge of administering medications to children with difficulty swallowing tablets or capsules. Liquid suspensions offer a palatable and easily swallowable alternative, ensuring accurate dosing for pediatric patients. Elderly individuals often face challenges associated with swallowing solid dosage forms. Pharmaceutical suspensions provide a convenient solution for geriatric patients who may experience difficulties in medication administration. This use enhances patient compliance and ensures elderly individuals receive their medications effectively.
Pharmaceutical suspensions are employed to improve the bioavailability of drugs with poor solubility. Converting poorly soluble compounds into suspensions increases the surface area for absorption, enhancing therapeutic efficacy. This application is crucial for drugs with low bioavailability that may otherwise exhibit suboptimal clinical outcomes. Taste masking is a significant application of pharmaceutical suspensions, particularly in pediatric formulations. Many drugs have unpleasant tastes that can be a barrier to medication adherence, especially in children. Suspending such drugs in a liquid form allows for the addition of flavoring agents, making the medication more palatable and increasing patient acceptance.
Cancer treatment often involves personalized medicine, and pharmaceutical suspensions in Canada allow customized formulations tailored to individual patient needs. The liquid nature of pharmaceutical suspensions allows for targeted drug delivery to specific tumour sites in Canada. This precision in drug delivery can enhance the therapeutic effect while minimizing side effects on healthy tissues in Canada. Hence, the factors mentioned above will drive the regional market growth.
The US market dominated the North America Pharmaceutical Suspension Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $18,546 million by 2030. The Canada market is experiencing a CAGR of 5.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 4.7% during (2023 - 2030).
Free Valuable Insights: The Pharmaceutical Suspension Market is Predict to reach $74.6 Billion by 2030, at a CAGR of 4.0%
Based on Type, the market is segmented into Parenteral, Oral, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on End User, the market is segmented into Hospitals and Clinics, Home Care Settings, and Others. Based on Indication, the market is segmented into Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Merck & Co., Inc.
- Bayer AG
- Sanofi S.A.
- Pfizer, Inc.
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly And Company
- Lupin Limited
North America Pharmaceutical Suspension Market Report Segmentation
By Type
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
By Indication
- Cancer
- Neurological
- Infectious Diseases
- Gastrointestinal
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pharmaceutical Suspension Market, by Type
1.4.2 North America Pharmaceutical Suspension Market, by Distribution Channel
1.4.3 North America Pharmaceutical Suspension Market, by End User
1.4.4 North America Pharmaceutical Suspension Market, by Indication
1.4.5 North America Pharmaceutical Suspension Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market
Chapter 5. North America Pharmaceutical Suspension Market by Type
5.1 North America Parenteral Market by Country
5.2 North America Oral Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Pharmaceutical Suspension Market by Distribution Channel
6.1 North America Drug Store & Retail Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Providers Market by Country
Chapter 7. North America Pharmaceutical Suspension Market by End User
7.1 North America Hospitals and Clinics Market by Country
7.2 North America Home Care Settings Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Pharmaceutical Suspension Market by Indication
8.1 North America Cancer Market by Country
8.2 North America Neurological Market by Country
8.3 North America Infectious Diseases Market by Country
8.4 North America Gastrointestinal Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Pharmaceutical Suspension Market by Country
9.1 US Pharmaceutical Suspension Market
9.1.1 US Pharmaceutical Suspension Market by Type
9.1.2 US Pharmaceutical Suspension Market by Distribution Channel
9.1.3 US Pharmaceutical Suspension Market by End User
9.1.4 US Pharmaceutical Suspension Market by Indication
9.2 Canada Pharmaceutical Suspension Market
9.2.1 Canada Pharmaceutical Suspension Market by Type
9.2.2 Canada Pharmaceutical Suspension Market by Distribution Channel
9.2.3 Canada Pharmaceutical Suspension Market by End User
9.2.4 Canada Pharmaceutical Suspension Market by Indication
9.3 Mexico Pharmaceutical Suspension Market
9.3.1 Mexico Pharmaceutical Suspension Market by Type
9.3.2 Mexico Pharmaceutical Suspension Market by Distribution Channel
9.3.3 Mexico Pharmaceutical Suspension Market by End User
9.3.4 Mexico Pharmaceutical Suspension Market by Indication
9.4 Rest of North America Pharmaceutical Suspension Market
9.4.1 Rest of North America Pharmaceutical Suspension Market by Type
9.4.2 Rest of North America Pharmaceutical Suspension Market by Distribution Channel
9.4.3 Rest of North America Pharmaceutical Suspension Market by End User
9.4.4 Rest of North America Pharmaceutical Suspension Market by Indication
Chapter 10. Company Profiles
10.1 Merck & Co., Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Bayer AG
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Sanofi S.A.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 SWOT Analysis
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Novartis AG
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 AstraZeneca PLC
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Glenmark Pharmaceuticals Limited
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 SWOT Analysis
10.8 Teva Pharmaceutical Industries Ltd.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.8.6 SWOT Analysis
10.9 Eli Lilly And Company
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Partnerships, Collaborations, and Agreements:
10.9.6 SWOT Analysis
10.10. Lupin Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:
10.10.5.2 Trials and Approvals:
10.10.6 SWOT Analysis
TABLE 1 North America Pharmaceutical Suspension Market, 2019 - 2022, USD Million
TABLE 2 North America Pharmaceutical Suspension Market, 2023 - 2030, USD Million
TABLE 3 North America Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
TABLE 4 North America Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
TABLE 5 North America Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Oral Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 12 North America Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 13 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
TABLE 20 North America Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
TABLE 21 North America Hospitals and Clinics Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Hospitals and Clinics Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Home Care Settings Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Home Care Settings Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
TABLE 28 North America Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
TABLE 29 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Neurological Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Neurological Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Infectious Diseases Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Infectious Diseases Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Gastrointestinal Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Gastrointestinal Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Pharmaceutical Suspension Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Pharmaceutical Suspension Market by Country, 2023 - 2030, USD Million
TABLE 41 US Pharmaceutical Suspension Market, 2019 - 2022, USD Million
TABLE 42 US Pharmaceutical Suspension Market, 2023 - 2030, USD Million
TABLE 43 US Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
TABLE 44 US Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
TABLE 45 US Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 US Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 US Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
TABLE 48 US Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
TABLE 49 US Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
TABLE 50 US Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
TABLE 51 Canada Pharmaceutical Suspension Market, 2019 - 2022, USD Million
TABLE 52 Canada Pharmaceutical Suspension Market, 2023 - 2030, USD Million
TABLE 53 Canada Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
TABLE 54 Canada Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
TABLE 55 Canada Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 Canada Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 Canada Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
TABLE 58 Canada Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
TABLE 59 Canada Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
TABLE 60 Canada Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
TABLE 61 Mexico Pharmaceutical Suspension Market, 2019 - 2022, USD Million
TABLE 62 Mexico Pharmaceutical Suspension Market, 2023 - 2030, USD Million
TABLE 63 Mexico Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
TABLE 64 Mexico Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
TABLE 65 Mexico Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Mexico Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 67 Mexico Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
TABLE 68 Mexico Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
TABLE 69 Mexico Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
TABLE 70 Mexico Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
TABLE 71 Rest of North America Pharmaceutical Suspension Market, 2019 - 2022, USD Million
TABLE 72 Rest of North America Pharmaceutical Suspension Market, 2023 - 2030, USD Million
TABLE 73 Rest of North America Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
TABLE 74 Rest of North America Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
TABLE 75 Rest of North America Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 76 Rest of North America Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 77 Rest of North America Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
TABLE 78 Rest of North America Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
TABLE 79 Rest of North America Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
TABLE 80 Rest of North America Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
TABLE 81 Key Information - Merck & Co., Inc.
TABLE 82 Key Information – Bayer AG
TABLE 83 Key Information – Sanofi S.A.
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Novartis AG
TABLE 86 KEY INFORMATION – AstraZeneca PLC
TABLE 87 Key Information – Glenmark Pharmaceuticals Limited
TABLE 88 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 89 Key Information – Eli Lilly And Company
TABLE 90 Key Information – Lupin Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Pharmaceutical Suspension Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pharmaceutical Suspension Market
FIG 4 Porter’s Five Forces Analysis - Pharmaceutical Suspension Market
FIG 5 North America Pharmaceutical Suspension Market share by Type, 2022
FIG 6 North America Pharmaceutical Suspension Market share by Type, 2030
FIG 7 North America Pharmaceutical Suspension Market by Type, 2019 - 2030, USD Million
FIG 8 North America Pharmaceutical Suspension Market share by Distribution Channel, 2022
FIG 9 North America Pharmaceutical Suspension Market share by Distribution Channel, 2030
FIG 10 North America Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 North America Pharmaceutical Suspension Market share by End User, 2022
FIG 12 North America Pharmaceutical Suspension Market share by End User, 2030
FIG 13 North America Pharmaceutical Suspension Market by End User, 2019 - 2030, USD Million
FIG 14 North America Pharmaceutical Suspension Market share by Indication, 2022
FIG 15 North America Pharmaceutical Suspension Market share by Indication, 2030
FIG 16 North America Pharmaceutical Suspension Market by Indication, 2019 - 2030, USD Million
FIG 17 North America Pharmaceutical Suspension Market share by Country, 2022
FIG 18 North America Pharmaceutical Suspension Market share by Country, 2030
FIG 19 North America Pharmaceutical Suspension Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Merck & Co., Inc.
FIG 21 Swot Analysis: Bayer AG
FIG 22 Swot Analysis: Sanofi S.A.
FIG 23 SWOT Analysis: Pfizer, Inc.
FIG 24 SWOT Analysis: Novartis AG
FIG 25 SWOT Analysis: AstraZeneca PLC
FIG 26 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 27 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 28 Swot Analysis: Eli Lilly And Company
FIG 29 SWOT Analysis: Lupin Limited